Delivery Order SPE2DB20D3101-SPE2DB25FRVM9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,266.52 to AmerisourceBergen Drug Corp for the supply of Acamprosate Calcium 333 mg tablets (180-count) with a completion deadline of September 12, 2025. This is a firm fixed price, non-competitive delivery order issued under a child contract arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,217.28 delivery order is for 180 tablets of acamprosate calcium delayed-release 333 mg, a medication used to treat alcohol dependence. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty thousand three hundred thirty-seven dollars to Amerisourcebergen Drug Corporation for the provision of three hundred thirty-three milligram tablets of acamprosate calcium in one hundred eighty count bottles. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over the period of September 19th through September 20th, 2023. The prime contractor, a division of...
- The Defense Logistics Agency awarded a delivery order valued at $1,219.17 to AmerisourceBergen Drug Corp on September 11, 2025, with an ultimate completion date of September 12, 2025. The order is for pharmaceutical products identified as "4569424878 ! DT 1C 2.25X4 700/RL 6RL/BX DHAPCL" under a firm fixed price contract type with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Fycompa 2 mg tablets (30-count units) valued at $1,493.69. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRUQAP 160 mg tablets (16-count units) valued at $15,959.30, with a firm fixed price structure and an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 1, 2025, with performance occurring at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,920.48 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 4, 2025 and represents a child order under a larger indefinite delivery contract vehicle. The award was not designated as a set-aside contract and reflects the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,963.84 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued under contract number 4569048102, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $166,465.43 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be delivered to the Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical and healthcare...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $1,122.53 from the Defense Logistics Agency's Medical Supply Chain on July 29, 2025. This firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance taking place at the awardee's corporate office in Conshohocken, PA. The contract represents a non-set-aside award, indicating open competition among...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVM9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,129.04 to AmerisourceBergen Drug Corp for 180 tablets of Acamprosate Calcium 333 mg, with an ultimate completion date of September 15, 2025. This non-competitive, firm fixed-price delivery order was issued on September 13, 2025, with performance to take place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through an open competition process to fulfill this federal medical procurement requirement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an umbrella pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. The award reflects the contractor's established capability to meet federal procurement requirements for pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and related medical supplies for the Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/13/25 |